By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

AtheroGenics, Inc. 

8995 Westside Parkway

Alpharetta  Georgia  30004  U.S.A.
Phone: 678-336-2500 Fax: 678-336-2501


SEARCH JOBS


Industry
Biotechnology

Segment
Drug Discovery





Company News
Delisting of Securities of AtheroGenics (AGIX) From The NASDAQ Stock Market 3/26/2009 9:13:51 AM
AtheroGenics (AGIX) Provides Update on Bankruptcy Proceedings 1/22/2009 11:21:17 AM
AtheroGenics (AGIX) Reports Third Quarter 2008 Financial Results 11/11/2008 8:33:09 AM
AtheroGenics (AGIX) Receives Delisting Notice From NASDAQ Global Market Due to Chapter 11 Filing 10/13/2008 9:12:03 AM
AtheroGenics (AGIX) Files for Chapter 11 Bankruptcy 10/7/2008 6:30:33 AM
AtheroGenics (AGIX) Restructures Board of Directors 9/11/2008 7:02:43 AM
AtheroGenics (AGIX) Seeks to Realign Capital Structure 9/2/2008 10:35:48 AM
AtheroGenics (AGIX) Noteholders Expect Company Will Elect Not to Pay 2008 Notes When Due 9/2/2008 9:09:25 AM
AtheroGenics (AGIX) Reports Second Quarter 2008 Financial Results 8/5/2008 10:29:50 AM
AtheroGenics (AGIX) Diabetes Drug Trial Meets Main Goal 7/31/2008 6:32:08 AM
12345678910...
//-->